• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Risks of cancer and mortality by average lifetime alcohol intake

Bioengineer by Bioengineer
June 19, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Free-Photos, Pixabay

The risk of mortality, and of developing a number of cancers, is lowest in light drinkers consuming an average of less than one drink per day across their lifetime, and the risk of some cancers increases with each additional drink per week, according to a new study, published this week in PLOS Medicine by Andrew Kunzmann of Queen's University Belfast, and colleagues.

In comparison, current U.S. guidelines recommend no more than 2 drinks per day for men and no more than 1 drink per day for women.

Even light-to-moderate levels of alcohol intake have previously been linked to increased cancer risk. At the same time, research has demonstrated a "J-shaped" risk curve relating alcohol intake to all-cause mortality, suggesting some protective effect of light-to-moderate drinking, particularly for death from cardiovascular disease. Those results have led to mixed public health messages. The new study analyzed whether combined risk of cancer or death from any cause differed in individuals with different alcohol intakes across their entire lifetime, using data from 99,654 individuals around the US who were followed for an average of 8.9 years as participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Alcohol use was measured using a diet history questionnaire administered between 1998 and 2000.

During the study, 9,559 deaths and 12,763 primary cancers occurred among the participants. The expected J-shaped relationship between overall mortality and alcohol consumption was seen: in comparison to lifetime light alcohol drinkers (1-3 drinks per week), lifetime never or infrequent drinkers (

The analysis is limited to older adults and may be confounded by socioeconomic factors, and the findings should not be taken to support a protective effect of light drinking, the authors caution.

"This study provides further insight into the complex relationship between alcohol consumption, cancer incidence, and disease mortality and may help inform public health guidelines," the authors say.

###

Research Article

Funding:

The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, and contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

Kunzmann AT, Coleman HG, Huang W-Y, Berndt SI (2018) The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study. PLoS Med 15(6): e1002585. https://doi.org/10.1371/journal.pmed.1002585

Author Affiliations:

Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002585

Media Contact

Andrew Kunzmann
[email protected]

Home

Related Journal Article

http://dx.doi.org/10.1371/journal.pmed.1002585

Share12Tweet7Share2ShareShareShare1

Related Posts

Gal-9 on Leukemia Stem Cells Predicts Prognosis

September 12, 2025

Enhancing Pediatric Radiology Education: Our Observership Insights

September 12, 2025

Evaluating Lung Function in Cystic Fibrosis: MRI Methods

September 12, 2025

PATZ1: Key Player in Tumorigenesis and Metabolism

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Polyacrylic Acid-Copper System Detects Gaseous Hydrogen Peroxide

Unveiling Arabidopsis Aminotransferases’ Multi-Substrate Specificity

Insights on Menstrual Health in Eating Disorder Units

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.